Picard Medical, Inc. (PMI)
NYSEAMERICAN: PMI · Real-Time Price · USD
4.610
-0.010 (-0.22%)
Sep 28, 2026, 4:00 PM EDT - Market closed
Picard Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Equivalents | 0.04 | 7.45 | 0.1 | 0.24 | 0.15 |
Cash & Short-Term Investments | 0.04 | 7.45 | 0.1 | 0.24 | 0.15 |
Cash Growth | -90.73% | 7661.46% | -60.66% | 60.53% | - |
Accounts Receivable | 0.61 | 0.62 | 0.51 | 0.63 | 0.88 |
Other Receivables | - | - | 0.11 | - | 2.76 |
Receivables | 0.61 | 0.76 | 0.63 | 0.74 | 3.64 |
Inventory | 5.97 | 7.3 | 8.12 | 6.89 | 7.33 |
Prepaid Expenses | 0.97 | 1.22 | 0.96 | 0.88 | 1 |
Restricted Cash | - | 4 | - | - | - |
Total Current Assets | 7.59 | 20.73 | 9.79 | 8.76 | 12.12 |
Property, Plant & Equipment | 0.5 | 0.7 | 1.1 | 1.31 | 1.93 |
Goodwill | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 |
Other Intangible Assets | 0.47 | 0.51 | 0.6 | 0.68 | 0.77 |
Total Assets | 9.17 | 22.55 | 12.11 | 11.37 | 15.44 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Accounts Payable | 3.32 | 2.08 | 5.29 | 3.08 | 1.39 |
Accrued Expenses | 0.96 | 1.36 | 2.37 | 1.76 | 0.72 |
Short-Term Debt | 1.27 | 6.45 | 5.15 | 4.06 | 0.62 |
Current Portion of Long-Term Debt | - | - | 14.83 | - | - |
Current Portion of Leases | 0.31 | 0.46 | 0.43 | 0.31 | 0.27 |
Other Current Liabilities | 1.59 | 8.34 | 7.25 | - | - |
Total Current Liabilities | 7.45 | 18.7 | 35.33 | 9.21 | 3 |
Long-Term Debt | - | - | - | 4.28 | - |
Long-Term Leases | - | 0.06 | 0.52 | 0.76 | 1.07 |
Other Long-Term Liabilities | - | - | - | 0.67 | - |
Total Liabilities | 7.45 | 18.76 | 35.84 | 14.93 | 4.07 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Common Stock | - | 0.01 | 0 | 0 | - |
Additional Paid-In Capital | 91.57 | 80.4 | 5.56 | 4.68 | 3.92 |
Retained Earnings | -90.12 | -76.84 | -49.84 | -28.79 | -13.22 |
Comprehensive Income & Other | 0.27 | 0.23 | 0.28 | 0.29 | 0.4 |
Total Common Equity | 1.72 | 3.79 | -44 | -23.82 | -8.9 |
Shareholders' Equity | 1.72 | 3.79 | -23.74 | -3.55 | 11.37 |
Total Liabilities & Equity | 9.17 | 22.55 | 12.11 | 11.37 | 15.44 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Total Debt | 1.58 | 6.98 | 20.93 | 9.41 | 1.96 |
Net Cash (Debt) | -1.54 | 0.48 | -20.83 | -9.17 | -1.81 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -1.04 | 0.66 | -131.12 | -57.70 | -16.16 |
Filing Date Shares Outstanding | 2.34 | 1.5 | 0.17 | 0.16 | 0.11 |
Total Common Shares Outstanding | 2.06 | 1.47 | 0.16 | 0.16 | 0.11 |
Working Capital | 0.14 | 2.03 | -25.53 | -0.45 | 9.12 |
Book Value Per Share | 0.83 | 2.57 | -276.96 | -149.91 | -79.55 |
Tangible Book Value | 0.64 | 2.67 | -45.21 | -25.12 | -10.28 |
Tangible Book Value Per Share | 0.31 | 1.81 | -284.58 | -158.09 | -91.95 |
Machinery | 0.71 | 0.68 | 0.65 | 0.72 | 0.9 |
Leasehold Improvements | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |